Unlike the routine detection of HER2, EGFR, BRAF, KRAS and other genes in breast cancer, lung cancer, colorectal cancer and other tumors, HCC has not yet an apparent gene-phenotype related to its prognosis and treatment due to its heterogeneity (18). This evidence concerns the gene KRAS and lung cancer.